Rare diseases
Investigational molecules
Locations
Back to Italy376 clinical trials in Bergamo, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
ItalyEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
ItalyStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
ItalyPremedication with dexamethasone to prevent interstitial lung disease in breast cancer patients receiving trastuzumab deruxtecan
ItalySafety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN
ItalyLong‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis
ItalyDB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
ItalyStudy of teclistamab plus autologous lymphocyte infusion in patients with relapsed or refractory multiple myeloma
ItalyA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
ItalyA study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer
ItalyA study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis
ItalyA study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for heart failure prevention and cardiovascular disease. Studies include evaluation of novel drug combinations and therapies for patients with elevated cardiovascular risks.
Comprehensive research focusing on various cancer types, including non-small cell lung cancer and prostate cancer. Studies evaluate innovative treatment approaches combining immunotherapy with traditional methods.
Specialized trials investigating treatments for conditions like Alagille syndrome and amyotrophic lateral sclerosis. Research focuses on improving patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
